Security key
000899104
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 238,388,839
- Total 13F shares
- 220,099,164
- Share change
- -819,337
- Total reported value
- $4,014,361,861
- Put/Call ratio
- 62%
- Price per share
- $18.24
- Number of holders
- 352
- Value change
- +$38,656,321
- Number of buys
- 189
- Number of sells
- 178
Report period
Q4 2025
Institutions
352
Top holders
10
ADMA full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
ADMA BIOLOGICS, INC. SEC filings
ADMA BIOLOGICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 000899104
Recent filing periods:
Top shareholders of ADMA - ADMA BIOLOGICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
|
Company |
15%
|
35,907,601
|
$865,732,260 | $0 | 31 Mar 2025 | |
| STATE STREET CORP |
13D/G
13F
|
STATE STREET CORPORATION · Company |
5.1%
|
12,078,505
|
$221,519,782 | +$11,695,913 | 30 Jun 2025 | |
| Invesco Ltd. |
13D/G
13F
|
Company |
5%
|
11,785,202
|
$211,308,672 | -$19,394,917 | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.8%
|
20,974,996
|
$307,493,442 | — | 30 Sep 2025 | |
| Sachem Head Capital Management LP |
13F
|
Company |
3.8%
|
8,960,000
|
$131,353,600 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
5,813,738
|
$85,241,510 | — | 30 Sep 2025 | |
| Nuveen, LLC |
13F
|
Company |
2.4%
|
5,724,145
|
$83,915,966 | — | 30 Sep 2025 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
2.1%
|
5,106,802
|
$74,865,717 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2%
|
4,798,274
|
$70,343,236 | — | 30 Sep 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
2%
|
4,695,923
|
$68,842,245 | — | 30 Sep 2025 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
1.7%
|
4,141,840
|
$60,719,000 | — | 30 Sep 2025 | |
| Capital Research Global Investors |
13F
|
Company |
1.4%
|
3,253,913
|
$47,702,365 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.2%
|
2,910,807
|
$42,672,430 | — | 30 Sep 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.2%
|
2,838,143
|
$104,304,510 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.2%
|
2,770,442
|
$40,614,680 | — | 30 Sep 2025 | |
| OBERWEIS ASSET MANAGEMENT INC/ |
13F
|
Company |
1.1%
|
2,712,040
|
$39,758,506 | — | 30 Sep 2025 | |
| Caligan Partners LP |
13F
|
Company |
1.1%
|
2,636,609
|
$38,652,688 | — | 30 Sep 2025 | |
| B Group, Inc. |
13F
|
Company |
1%
|
2,412,542
|
$35,367,866 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.99%
|
2,360,780
|
$34,609,035 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.99%
|
2,360,765
|
$34,608,815 | — | 30 Sep 2025 | |
| Ranger Investment Management, L.P. |
13F
|
Company |
0.98%
|
2,340,730
|
$34,315,102 | — | 30 Sep 2025 | |
| AWM Investment Company, Inc. |
13F
|
Company |
0.92%
|
2,200,000
|
$32,252,000 | — | 30 Sep 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.9%
|
2,155,662
|
$31,603,000 | — | 30 Sep 2025 | |
| Perpetual Ltd |
13F
|
Company |
0.89%
|
2,119,291
|
$31,068,806 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.89%
|
2,119,162
|
$31,066,915 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.83%
|
1,987,673
|
$29,139,286 | — | 30 Sep 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.72%
|
1,718,044
|
$25,186,525 | — | 30 Sep 2025 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.65%
|
1,548,139
|
$23,299,492 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.61%
|
1,458,194
|
$21,377,148 | — | 30 Sep 2025 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.61%
|
1,454,150
|
$21,317,839 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.6%
|
1,423,450
|
$20,867,781 | — | 30 Sep 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.59%
|
1,405,845
|
$20,609,000 | — | 30 Sep 2025 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.59%
|
1,395,099
|
$20,452,000 | — | 30 Sep 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.55%
|
1,323,041
|
$19,395,780 | — | 30 Sep 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.55%
|
1,322,016
|
$19,380,755 | — | 30 Sep 2025 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.55%
|
1,310,034
|
$19,205,098 | — | 30 Sep 2025 | |
| Ophir Asset Management Pty Ltd |
13F
|
Company |
0.53%
|
1,255,235
|
$18,401,745 | — | 30 Sep 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.53%
|
1,251,796
|
$18,351,331 | — | 30 Sep 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.52%
|
1,237,424
|
$18,140,651 | — | 30 Sep 2025 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.5%
|
1,181,011
|
$17,313,621 | — | 30 Sep 2025 | |
| PERCEPTIVE ADVISORS LLC |
3/4/5
13F
|
10%+ Owner · Company |
0.48%
from 13F
|
13,262,375
|
$59,945,935 | — | 28 Sep 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.47%
|
1,124,676
|
$16,487,750 | — | 30 Sep 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.47%
|
1,116,312
|
$16,365,134 | — | 30 Sep 2025 | |
| First Light Asset Management, LLC |
13F
|
Company |
0.45%
|
1,069,233
|
$15,674,956 | — | 30 Sep 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.44%
|
1,050,000
|
$15,393,000 | — | 30 Sep 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.43%
|
1,018,239
|
$14,927,384 | — | 30 Sep 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.39%
|
932,068
|
$13,664,117 | — | 30 Sep 2025 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.39%
|
930,800
|
$13,645,528 | — | 30 Sep 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.38%
|
898,028
|
$13,165,090 | — | 30 Sep 2025 | |
| First Turn Management, LLC |
13F
|
Company |
0.34%
|
808,673
|
$11,855,146 | — | 30 Sep 2025 |
Institutional Holders of ADMA BIOLOGICS, INC. - Common Stock (ADMA) as of Q4 2025
As of 31 Dec 2025,
ADMA BIOLOGICS, INC. - Common Stock (ADMA) was held by
352 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
220,099,164 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, Invesco Ltd., Sachem Head Capital Management LP, WESTFIELD CAPITAL MANAGEMENT CO LP, Capital Research Global Investors, Nuveen, LLC, GEODE CAPITAL MANAGEMENT, LLC, and AMERICAN CENTURY COMPANIES INC.
This page lists
353
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
359
Q4 2025 holders
352
Holder diff
-7
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.